Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Page 1
Metastasis-directed SBRT for oligometastatic hormone sensitive prostate cancer (METRO): protocol for a prospective randomised phase III trial, NCT04983095.
Söderkvist K, Zia M, Gunnlaugsson A, Josefsson A, Aksnessæther B, Li C, Thellenberg-Karlsson C, Alm D, Kudrén D, Lundin E, Moise G, Brandell JK, Kindblom J, Björnlinger K, Karlsson K, Riklund K, Westin M, Hedman M, Skorve N, Wikström P, Strandberg S, Jonsson J. Söderkvist K, et al. BMC Cancer. 2026 Mar 25;26(1):456. doi: 10.1186/s12885-026-15906-6. BMC Cancer. 2026. PMID: 41882599 Free PMC article.
Self-help cognitive behavioural therapy for hot flushes and night sweats during androgen deprivation therapy for prostate cancer: the MANCAN2 randomized controlled trial.
Crabb SJ, Morgan A, Stefanopoulou E, Fleure L, Griffiths GO, Boxall C, Wilding S, Nearchou T, Ewings S, Nuttall J, Eminton Z, Tilt E, Whitby E, Siu B, Ridley P, Robson L, Nobes J, Preece J, Bacon R, Martin J, Chamberlain S, Fenlon D, Hunter M, Richardson A. Crabb SJ, et al. Br J Cancer. 2026 May;134(10):1413-1419. doi: 10.1038/s41416-026-03375-4. Epub 2026 Mar 24. Br J Cancer. 2026. PMID: 41872531 Free PMC article. Clinical Trial.
Psychosocial factors and the risk of cancer: An individual-participant data meta-analysis.
van Tuijl LA, Pan KY, Basten M, Vermeulen R, Portengen L, de Graeff A, Dekker J, Geerlings MI, Hoogendoorn AW, Lamers F, Voogd AC, Abell J, Awadalla P, Beekman ATF, Bjerkeset O, Boyd A, Cui Y, Frank P, Galenkamp H, Garssen B, Hellingman S, Huisman M, Huss A, de Jong TR, Keats MR, Kok AAL, Krokstad S, van Leeuwen FE, Luik AI, Noisel N, Payette Y, Penninx BWJH, Rissanen I, Roest AM, Ruiter R, Schoevers RA, Soave D, Spaan M, Steptoe A, Stronks K, Sund ER, Sweeney E, Twait EL, Teyhan A, Verschuren WMM, van der Willik KD, Rosmalen JGM, Ranchor AV. van Tuijl LA, et al. Cancer. 2026 Apr 1;132(7):e70271. doi: 10.1002/cncr.70271. Cancer. 2026. PMID: 41866892 Free PMC article.
AI-discovered cellular morphometric biomarkers in needle biopsy of prostate cancer predict neoadjuvant androgen deprivation therapy response and enable therapeutic targeting of mTOR in androgen deprivation therapy-resistant tumors.
Yan H, Mao AW, Li D, Fu G, Pérez-Baena MJ, Jiménez-Navas A, Wang D, Hong R, Cai W, Pérez-Losada J, Jen KY, Wang S, Peng S, Barcellos-Hoff MH, Shen H, Lin N, Mao JH, Fu Y, Iczkowski KA, Gulati S, Chang H. Yan H, et al. Cancer Lett. 2026 Jun 1;647:218447. doi: 10.1016/j.canlet.2026.218447. Epub 2026 Mar 24. Cancer Lett. 2026. PMID: 41887393 Free article.
Single-Cell and Spatial Transcriptomic Profiling Reveals Epithelial Functional States and Fibroblast Phenotypes in Hormone Therapy-Naïve Localized Prostate Cancer.
Apostolov E, Roden DL, Holliday H, Cazet A, Harvey K, Zhang H, Wu SZ, van der Leij S, Jieun Kim H, Selth LA, Bartonicek N, Al-Eryani G, Reeves JL, He M, Lundeberg J, Potter AJ, Kench JG, Stricker PD, Joshua AM, Horvath LG, Swarbrick A. Apostolov E, et al. Cancer Res. 2026 Apr 15;86(8):1836-1853. doi: 10.1158/0008-5472.CAN-25-1202. Cancer Res. 2026. PMID: 41879555
Carboplatin, Cabazitaxel, and Abiraterone in High-Volume Metastatic Castration-Sensitive Prostate Cancer: The CASCARA Phase II Study.
Antonarakis ES, Cao Q, Catharine V, Carneiro BA, De Souza AL, VanderWeele DJ, Singh P, Bryce AH, Kelly WK, Jha GG, Lewis B, Barata PC, Sartor AO, Stadler WM, Proudfoot JA, Davicioni E, Dhawan M, Morgans AK, Ryan CJ. Antonarakis ES, et al. Clin Cancer Res. 2026 Jun 15;32(12):2403-2412. doi: 10.1158/1078-0432.CCR-25-4823. Clin Cancer Res. 2026. PMID: 41880596 Clinical Trial.
Pushing the Boundaries of Stereotactic Body Radiation Therapy in Irradiated Territories for Nodal Oligorecurrent Prostate Cancer: Outcomes of the CYGNUS Multicentric Retrospective Study.
Anger E, Supiot S, Josset Q, Pasquier D, Vaugier L, Riet FG, Pointreau Y, Ruffier A, Loos G, Terlizzi M, Blanchard P, Martin E, Sargos P, Guerni M, Schick U, Bera G, Roman J, Latorzeff I, Créhange G, Castelli J, Barateau A, De Crevoisier R, Nicosia L, Le Guévelou J. Anger E, et al. Int J Radiat Oncol Biol Phys. 2026 Mar 19:S0360-3016(26)00502-X. doi: 10.1016/j.ijrobp.2026.03.020. Online ahead of print. Int J Radiat Oncol Biol Phys. 2026. PMID: 41864432
17 results